Alexandra Mancini
2023
In 2023, Alexandra Mancini earned a total compensation of $284.9K as Senior Vice President, Clinical & Regulatory Affairs at InMed Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Bonus | $41,611 |
|---|---|
| Option Awards | $5,531 |
| Salary | $237,778 |
| Total | $284,920 |
Mancini received $237.8K in salary, accounting for 83% of the total pay in 2023.
Mancini also received $41.6K in bonus and $5.5K in option awards.
Rankings
In 2023, Alexandra Mancini's compensation ranked 2,420th out of 2,770 executives tracked by ExecPay. In other words, Mancini earned more than 12.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,420 out of 2,770 | 13th |
Division Manufacturing | 1,344 out of 1,516 | 11th |
Major group Chemicals And Allied Products | 785 out of 855 | 8th |
Industry group Drugs | 764 out of 821 | 7th |
Industry Pharmaceutical Preparations | 543 out of 590 | 8th |
Source: SEC filing on October 27, 2023.
Mancini's colleagues
We found four more compensation records of executives who worked with Alexandra Mancini at InMed Pharmaceuticals in 2023.
2023
Eric Adams
InMed Pharmaceuticals
Chief Executive Officer
2023
Michael Woudenberg
InMed Pharmaceuticals
Chief Operating Officer
2023
Eric Hsu
InMed Pharmaceuticals
Senior Vice President, Preclinical Research & Development
2023
Jonathan Tegge
InMed Pharmaceuticals
Chief Financial Officer
News
InMed Pharmaceuticals CEO Eric Adams' 2024 pay rises 13% to $415K
October 28, 2024
InMed Pharmaceuticals CEO Eric Adams' 2023 pay falls 22% to $368K
October 27, 2023
InMed Pharmaceuticals CEO Eric Adams' 2022 pay falls 36% to $468K
October 28, 2022
InMed Pharmaceuticals CEO Eric Adams' 2021 pay jumps 73% to $735K
October 28, 2021